Geneva Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
5,173
+636
| +14% | +$258K | 0.04% | 111 |
|
|
2025
Q1 | $2.26M | Sell |
4,537
-79
| -2% | -$39.3K | 0.04% | 109 |
|
|
2024
Q4 | $2.4M | Sell |
4,616
-332
| -7% | -$173K | 0.04% | 115 |
|
|
2024
Q3 | $3.06M | Sell |
4,948
-430
| -8% | -$266K | 0.05% | 111 |
|
|
2024
Q2 | $2.97M | Sell |
5,378
-1,341
| -20% | -$742K | 0.05% | 113 |
|
|
2024
Q1 | $3.91M | Sell |
6,719
-336
| -5% | -$195K | 0.07% | 106 |
|
|
2023
Q4 | $3.74M | Sell |
7,055
-354
| -5% | -$188K | 0.07% | 104 |
|
|
2023
Q3 | $3.75M | Buy |
7,409
+644
| +10% | +$326K | 0.08% | 106 |
|
|
2023
Q2 | $3.53M | Sell |
6,765
-287
| -4% | -$150K | 0.07% | 105 |
|
|
2023
Q1 | $4.06M | Sell |
7,052
-526
| -7% | -$303K | 0.08% | 102 |
|
|
2022
Q4 | $4.17M | Sell |
7,578
-822
| -10% | -$453K | 0.09% | 104 |
|
|
2022
Q3 | $4.26M | Sell |
8,400
-3
| -0% | -$1.52K | 0.1% | 106 |
|
|
2022
Q2 | $4.57M | Sell |
8,403
-93
| -1% | -$50.5K | 0.11% | 104 |
|
|
2022
Q1 | $5.02M | Buy |
8,496
+106
| +1% | +$62.6K | 0.1% | 111 |
|
|
2021
Q4 | $5.6M | Sell |
8,390
-201
| -2% | -$134K | 0.09% | 108 |
|
|
2021
Q3 | $4.91M | Sell |
8,591
-254
| -3% | -$145K | 0.08% | 112 |
|
|
2021
Q2 | $4.46M | Sell |
8,845
-36
| -0.4% | -$18.2K | 0.07% | 112 |
|
|
2021
Q1 | $4.05M | Sell |
8,881
-91
| -1% | -$41.5K | 0.07% | 114 |
|
|
2020
Q4 | $4.18M | Buy |
8,972
+12
| +0.1% | +$5.59K | 0.07% | 113 |
|
|
2020
Q3 | $3.96M | Buy |
8,960
+79
| +0.9% | +$34.9K | 0.08% | 107 |
|
|
2020
Q2 | $3.22M | Buy |
8,881
+79
| +0.9% | +$28.6K | 0.07% | 108 |
|
|
2020
Q1 | $2.5M | Buy |
+8,802
| New | +$2.5M | 0.07% | 110 |
|